Comparison of the Resection Site Order in Simultaneous Approach of Colorectal Liver Metastasis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAzienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

About this trial

Colorectal cancer frequently presents with liver metastases, and complete removal of both primary and liver tumors can significantly improve survival. Simultaneous resection (SA) of the colon and liver is increasingly used and is considered safe when minor liver resections are performed, offering advantages such as shorter hospitalization, fewer complications, and faster chemotherapy initiation.

However, the best sequence of resection, liver-first or colon-first, remains uncertain, as each has potential benefits and drawbacks, particularly regarding anastomotic healing. Minimally invasive approaches to SA show similar outcomes to open surgery, though limited data suggest that resection order may affect blood loss.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients diagnosed with colorectal cancer with synchronous liver metastases during the reference period, who underwent simultaneous resection.

Disqualifiers

Simultaneous emergency resection due to symptoms of the primary tumor.

Presence of extrahepatic metastatic disease confirmed at the time of resection or diagnosis.

High surgical risk defined as an ASA risk score greater than 3.

At least 10 cases performed by the invited center during the study period.

Trial population

Patients undergoing simultaneous treatment of colorectal cancer and liver metastases using open, laparoscopic, and robotic surgery between 2015 and 2023 in participating centers

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Data collection

    Procedure/Surgery

    Data collection to assess whether the order of resection of the site in a simultaneous approach (liver first vs. colon first) in colorectal cancer with liver metastases affects overall postoperative morbidity.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Difference in overall morbidity rates

Measurement of the difference in overall morbidity rates between both approaches (liver first vs. colon first) in colorectal cancer with liver metastasis influences postoperative

Time frame
Through study completion, an average of 1 year

Secondary outcomes

1

Mortality

Evaluation of the postoperative mortality for both approaches, (liver first vs. colon first), when performed via laparoscopic or robotic surgery

Time frame
Through study completion, an average of 1 year
2

Overall survival

Compare the overall survival of patients with a diagnosis of colorectal cancer between both approaches (liver first vs. colon first), when performed via laparoscopic or robotic surgery

Time frame
Through study completion, an average of 1 year
3

Disease-free survival

Compare the disease-free survival of patients with a diagnosis of colorectal cancer between both approaches (liver first vs. colon first), when performed via laparoscopic or robotic surgery

Time frame
Through study completion, an average of 1 year
4

Recurrence sites

Compare the recurrence sites in patients with a diagnosis of colorectal cancer between both approaches (liver first vs. colon first), when performed via laparoscopic or robotic surgery

Time frame
Through study completion, an average of 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.